Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Maria Jesús

Maria Jesús Bullido Gómez-Heras, Madrid ES

Patent application numberDescriptionPublished
20100304384METHOD OF IDENTIFYING COMPOUNDS THAT INDUCE OR INHIBIT ENDOPLASMIC RETICULUM STRESS OR OXIDATIVE STRESS - The present invention generally relates to a method for the identification of compounds for the treatment of neurodegenerative diseases. Said method is based on a cell model for neurodegeneration useful for the identification of potentially useful compounds for the treatment or the prevention of a neurodegenerative disease associated with deficient expression of the DDIT3 gene, also known as CHOP.12-02-2010

Maria Jesús Bullido Gómez-Heras, Madrid ES

Patent application numberDescriptionPublished
20100304384METHOD OF IDENTIFYING COMPOUNDS THAT INDUCE OR INHIBIT ENDOPLASMIC RETICULUM STRESS OR OXIDATIVE STRESS - The present invention generally relates to a method for the identification of compounds for the treatment of neurodegenerative diseases. Said method is based on a cell model for neurodegeneration useful for the identification of potentially useful compounds for the treatment or the prevention of a neurodegenerative disease associated with deficient expression of the DDIT3 gene, also known as CHOP.12-02-2010

Maria Jesús Muñoz Gonzalvo, Zaragoza ES

Patent application numberDescriptionPublished
20100261656Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin - The present invention relates to the therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin and of the polypeptide encoded by said sequence, preferably for the treatment of amyotrophic lateral sclerosis (ALS).10-14-2010

Maria Jesús Muñoz Gonzalvo, Zaragoza ES

Patent application numberDescriptionPublished
20100261656Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin - The present invention relates to the therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin and of the polypeptide encoded by said sequence, preferably for the treatment of amyotrophic lateral sclerosis (ALS).10-14-2010

Maria Jesús Vicent Docon, Castellon ES

Patent application numberDescriptionPublished
20090298781COMPOUNDS FOR THE INHIBITION OF APOPTOSIS - The present invention relates to compounds of formula (I) as well as to drug conjugates based on compounds of formula (I) acting as apoptosis inhibitors, as well as to processes for their preparation, to pharmaceutical compositions containing them and their use in medicine.12-03-2009

Maria Jesús Vicent Docon, Castellon ES

Patent application numberDescriptionPublished
20090298781COMPOUNDS FOR THE INHIBITION OF APOPTOSIS - The present invention relates to compounds of formula (I) as well as to drug conjugates based on compounds of formula (I) acting as apoptosis inhibitors, as well as to processes for their preparation, to pharmaceutical compositions containing them and their use in medicine.12-03-2009